Depomed (DEPO) Tops Q3 EPS by 3c, Revenue Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mail
Get Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Interest and other income: 113K
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Interest and other income: 113K
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q3 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. Revenue for the quarter came in at $95 million versus the consensus estimate of $99.57 million.
GUIDANCE:
Depomed sees FY2017 revenue of $375-380 million, versus the consensus of $393.6 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank's top picks in mining as copper market faces potential squeeze
- Parabolic reports preliminary Q3 2026 revenue of $4.7 million
- Hess Midstream stock drops on Chevron restructuring and lower 2027 outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
